Infectious disease with peripheral neuropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:206613
Who is this for?
Show terms as
18Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infectious disease with peripheral neuropathy is a grouping classification used by Orphanet (ORPHA:206613) to categorize conditions in which peripheral neuropathy occurs as a consequence of an infectious agent. Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves — the nerves outside the brain and spinal cord — leading to symptoms such as numbness, tingling, weakness, and pain, typically in the hands and feet. Several well-known infectious diseases can cause peripheral neuropathy, including leprosy (caused by Mycobacterium leprae), HIV/AIDS, Lyme disease (Borrelia burgdorferi), hepatitis C, diphtheria, and certain viral infections such as varicella-zoster (shingles). The mechanisms by which infections damage peripheral nerves vary and may include direct nerve invasion by the pathogen, immune-mediated nerve damage, or toxin-related injury. The body systems primarily affected include the peripheral nervous system, but depending on the underlying infectious agent, other organ systems such as the skin, liver, musculoskeletal system, and immune system may also be involved. Key clinical features of the peripheral neuropathy component include sensory disturbances (numbness, paresthesias, neuropathic pain), motor weakness, and in some cases autonomic dysfunction (such as abnormal sweating, blood pressure changes, or gastrointestinal symptoms). The severity and pattern of neuropathy depend on the specific infectious etiology. Treatment is directed at the underlying infectious cause and may include antibiotics, antivirals, or antiretroviral therapy, depending on the pathogen involved. Symptomatic management of neuropathic pain with medications such as gabapentin, pregabalin, or tricyclic antidepressants may also be employed. Physical therapy and rehabilitation can help manage motor deficits. Early identification and treatment of the causative infection is critical to preventing irreversible nerve damage.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Jan 2026New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis

Centre Hospitalier Universitaire de Nīmes

TrialRECRUITING
Apr 2025Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

CMH Kharian Medical College — NA

TrialRECRUITING
Jun 2024Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia

Huazhong University of Science and Technology

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Infectious disease with peripheral neuropathy.

View clinical trials →

No actively recruiting trials found for Infectious disease with peripheral neuropathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Infectious disease with peripheral neuropathy community →

Specialists

18 foundView all specialists →
RF
Ruggero G Fariello, MD FAAN
Specialist
PI on 1 active trial
DM
Daniel R Malan, MD
BOISE, ID
Specialist
PI on 1 active trial
QL
Qianjin Lu
Specialist
PI on 5 active trials110 Infectious disease with peripheral neuropathy publications
RP
Robert Sandoval, MS, PT
Specialist
PI on 1 active trial
DP
David M Kietrys, PhD
Specialist
PI on 1 active trial
JJ
John A Jermano
Specialist
PI on 1 active trial
JD
Joyce K Anastasi, PhD, DrNP
Specialist
PI on 1 active trial
GM
Gere diZerega, MD
LOS ANGELES, CA
Specialist
PI on 1 active trial1 Infectious disease with peripheral neuropathy publication
YM
Yang Shuguang, M.D
Specialist
PI on 1 active trial
JP
Jens A Sørensen, MD. PhD.
Specialist
PI on 1 active trial
DM
Deepika E Slawek, MD, MPH, MS
NEW YORK, NY
Specialist
PI on 2 active trials
MF
Mohammed A El-Bayoumi, MD, FRCPCH
Specialist
PI on 1 active trial
MH
Misty D Humphries
BURLINGTON, NC
Specialist
PI on 1 active trial10 Infectious disease with peripheral neuropathy publications
SP
Seong-Soo Choi, MD, PhD
Specialist
PI on 1 active trial
JP
Jens Ahm Sorensen, Prof
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Infectious disease with peripheral neuropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Infectious disease with peripheral neuropathyForum →

No community posts yet. Be the first to share your experience with Infectious disease with peripheral neuropathy.

Start the conversation →

Latest news about Infectious disease with peripheral neuropathy

Disease timeline:

New recruiting trial: New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis

A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy

New recruiting trial: Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy

New recruiting trial: Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia

A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Infectious disease with peripheral neuropathy

What is Infectious disease with peripheral neuropathy?

Infectious disease with peripheral neuropathy is a grouping classification used by Orphanet (ORPHA:206613) to categorize conditions in which peripheral neuropathy occurs as a consequence of an infectious agent. Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves — the nerves outside the brain and spinal cord — leading to symptoms such as numbness, tingling, weakness, and pain, typically in the hands and feet. Several well-known infectious diseases can cause peripheral neuropathy, including leprosy (caused by Mycobacterium leprae), HIV/AIDS, Lyme disease (Borrelia bur

Which specialists treat Infectious disease with peripheral neuropathy?

18 specialists and care centers treating Infectious disease with peripheral neuropathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.